Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.14 USD | -3.48% | -9.45% | -15.10% |
09/05 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
08/05 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.10% | 769M | |
+3.19% | 108B | |
+10.44% | 104B | |
+0.82% | 22.33B | |
-11.90% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-8.84% | 17.64B | |
+6.47% | 14.05B | |
+36.93% | 12.51B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Leerink Partners Upgrades REGENXBIO to Outperform From Market Perform